- Home
- KRRO vs IXHL Comparison
KRRO vs IXHL Comparison
Compare KRRO & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- IXHL
- Stock Information
- Founded
- KRRO 2014
- IXHL 2001
- Country
- KRRO United States
- IXHL Australia
- Employees
- KRRO N/A
- IXHL N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- IXHL
- Sector
- KRRO Health Care
- IXHL
- Exchange
- KRRO Nasdaq
- IXHL Nasdaq
- Market Cap
- KRRO 58.6M
- IXHL 49.1M
- IPO Year
- KRRO 2019
- IXHL N/A
- Fundamental
- Price
- KRRO $5.59
- IXHL $0.36
- Analyst Decision
- KRRO Buy
- IXHL
- Analyst Count
- KRRO 10
- IXHL 0
- Target Price
- KRRO $74.17
- IXHL N/A
- AVG Volume (30 Days)
- KRRO 1.0M
- IXHL 17.0M
- Earning Date
- KRRO 11-12-2025
- IXHL 11-14-2025
- Dividend Yield
- KRRO N/A
- IXHL N/A
- EPS Growth
- KRRO N/A
- IXHL N/A
- EPS
- KRRO N/A
- IXHL N/A
- Revenue
- KRRO $7,371,000.00
- IXHL $12,000.00
- Revenue This Year
- KRRO $116.91
- IXHL $1,188.37
- Revenue Next Year
- KRRO N/A
- IXHL $3,569.49
- P/E Ratio
- KRRO N/A
- IXHL N/A
- Revenue Growth
- KRRO N/A
- IXHL N/A
- 52 Week Low
- KRRO $5.42
- IXHL $0.08
- 52 Week High
- KRRO $56.69
- IXHL $2.25
- Technical
- Relative Strength Index (RSI)
- KRRO 21.22
- IXHL 49.50
- Support Level
- KRRO $5.42
- IXHL $0.30
- Resistance Level
- KRRO $6.59
- IXHL $0.34
- Average True Range (ATR)
- KRRO 1.20
- IXHL 0.02
- MACD
- KRRO -0.82
- IXHL 0.00
- Stochastic Oscillator
- KRRO 0.70
- IXHL 75.98
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.